Vascepa, a prescription omega-3 fatty acid, is effective in reducing heart disease risk. The medication reduces inflammation and has helped reduce major adverse cardiovascular events by 25% in patients with high triglycerides and established cardiovascular disease, according to the REDUCE-IT trial. Other studies also found Vascepa reduced the risk of cardiovascular events by 18%. The average cost of Vascepa is around $250 per month.
Cybersecurity in the healthcare industry safeguarding critical patient data in 2025
The article discusses the importance of cybersecurity in the healthcare industry, particularly in safeguarding critical patient data by 2025.
